TW202131939A - Pharmaceutical composition for itching stop and sensitizing relief and manufacturing method thereof wherein the composition includes nepeta, parsnip, Kochia scoparia, Cortex Dictamni and other herbal extracts - Google Patents

Pharmaceutical composition for itching stop and sensitizing relief and manufacturing method thereof wherein the composition includes nepeta, parsnip, Kochia scoparia, Cortex Dictamni and other herbal extracts Download PDF

Info

Publication number
TW202131939A
TW202131939A TW109105886A TW109105886A TW202131939A TW 202131939 A TW202131939 A TW 202131939A TW 109105886 A TW109105886 A TW 109105886A TW 109105886 A TW109105886 A TW 109105886A TW 202131939 A TW202131939 A TW 202131939A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
itching
nepeta
parsnip
desensitization
Prior art date
Application number
TW109105886A
Other languages
Chinese (zh)
Inventor
呂秉勳
張貴珠
Original Assignee
欣綠智國際企業有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 欣綠智國際企業有限公司 filed Critical 欣綠智國際企業有限公司
Priority to TW109105886A priority Critical patent/TW202131939A/en
Publication of TW202131939A publication Critical patent/TW202131939A/en

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a pharmaceutical composition for itching stop and sensitizing relief, which is characterized in that the pharmaceutical composition contains nepeta, parsnip, Kochia scoparia, Cortex Dictamni and other herbal extracts. The pharmaceutical composition with such ingredients may generate anti-inflammation, blood invigorating and nourishing, and skin repairing effects after being applied to wounds or places where diseases occur. Because of being composed of pure natural kampo herbs, the pharmaceutical composition can stay on wounds or itching places for a longer time and is more efficient to repairs of the wounds and the improvement of the anti-itching effect. At the same time, because of being composed of natural herbs, the pharmaceutical composition will not cause other damage to the skin, such as allergies, even if it stays on the wounds for a long time.

Description

止癢脫敏之醫藥組合物及其產品之製備方法Antipruritic and desensitizing medicinal composition and preparation method of its product

本發明係醫藥品之領域,尤其是一種能夠止癢脫敏之醫藥組合物及其產品之製備方法。The present invention is in the field of pharmaceuticals, especially a pharmaceutical composition capable of relieving itching and desensitization and a preparation method of its product.

按,尿毒性搔癢症(uremic pruritus)是末期腎臟病(ESRD)病患常見並感到困擾的一種症狀,其病生理機轉尚未被完全了解,且症狀雖能經過治療後減輕卻非常難以根除。尿毒搔癢症的盛行率在成年透析病患的盛行率逐年變異相當大,有些研究認為透析效率的增加可能降低盛行率,以解釋其盛行率由1980和1993年的50及90%,到後續研究報告顯示的22~57%;另一項大型研究(the Dialysis Outcomes and Practice Patterns Study [DOPPS])則顯示成人透析病患的尿毒搔癢症盛行率為42%。According to statistics, uremic pruritus (uremic pruritus) is a common and distressing symptom in patients with end-stage renal disease (ESRD). Its pathophysiology has not been fully understood, and although the symptoms can be relieved after treatment, it is very difficult to eradicate. The prevalence rate of uremia pruritus in adult dialysis patients varies considerably from year to year. Some studies suggest that the increase in dialysis efficiency may reduce the prevalence rate to explain its prevalence rate from 50 and 90% in 1980 and 1993 to follow-up studies. The report shows 22~57%; another large study (the Dialysis Outcomes and Practice Patterns Study [DOPPS]) shows that the prevalence rate of uremia in adult dialysis patients is 42%.

尿毒搔癢症最好發的部位在背部,但手臂、頭部及腹部也可能出現,也有許多病人為全身性的搔癢,發生的頻率從每日數分鐘到幾乎沒有間斷的持續性搔癢、過敏不等。常見的特徵還有夜間惡化,進而影響睡眠品質,這種情況在較嚴重的尿毒搔癢病患身上出現,甚至會使病人產生疲倦及憂鬱的情形;而高溫(特別是大量出汗的情況)及壓力也會加重搔癢的症狀。另外有些病患於透析時搔癢的情況會加重,有些則是減輕。Uremia pruritus is most commonly found on the back, but arms, head and abdomen may also occur. There are also many patients with systemic pruritus. The frequency of occurrence ranges from a few minutes a day to almost uninterrupted persistent pruritus and allergies. Wait. Common features include deterioration at night, which affects the quality of sleep. This condition occurs in patients with more severe uremia and scrapie, and can even make the patient tired and depressed; and high temperature (especially in the case of a lot of sweating) and Stress can also aggravate the symptoms of itching. In addition, some patients experience increased itching during dialysis, while others are lessened.

並且,尿毒搔癢症的病患皮膚容易乾燥,會出現鱗狀表現或表皮龜裂,因為反覆搔抓產生顯著的皮膚變化,如表皮剝落(excoriations)、單純性苔癬(lichen simplex)、結節性癢疹(pruritus nodularis)、角化性丘疹(keratotic papules)毛囊性皮膚角化症(follicular hyperkeratosis)及後天穿透性皮膚病(Acquired perforating dermatosis, APD)。In addition, patients with uremic pruritus are prone to dry skin, scaly appearance or epidermal cracking, because repeated scratching produces significant skin changes, such as epidermal exfoliation (excoriations), simple lichen simplex (lichen simplex), nodularity Pruritus nodularis, keratotic papules, follicular hyperkeratosis and Acquired perforating dermatosis (APD).

由於搔癢的症狀在透析病人非常常見,因此除非有一致且有說服力的證據顯示病患的搔癢是源自其他原因的情況,否則臨床上會先假設病患的搔癢是來自於尿毒搔癢。臨床診斷上可以參考的特徵包含有:開始透析時伴隨搔癢發生、症狀持續不間斷、顯著的鈣磷鎂離子、副甲狀腺素、血清尿素氮的濃度升高。Because the symptoms of itching are very common in dialysis patients, unless there is consistent and convincing evidence that the patient's itching is due to other causes, clinically, it will be assumed that the patient's itching is from uremic itching. The characteristics that can be referred to in clinical diagnosis include: the occurrence of itching at the beginning of dialysis, the continuous uninterrupted symptoms, and the significant increase in the concentration of calcium, phosphorus and magnesium ions, parathyroid hormone, and serum urea nitrogen.

又,由於對於尿毒搔癢症的病生理機制尚未全部研究透徹,故目前仍然無法找到最有效的治療方式,對於患有嚴重搔癢症的患者,儘管達到了最佳的Kt/V目標,搔癢仍無法改善。尿毒搔癢症的治療方式尚有使用口服抗組織胺藥和gabapentin、外用潤膚劑或局部鎮痛劑、紫外線B (UVB)光療法和腎移植。然而臨床上有許多頑固性尿毒搔癢症的患者接受以上的治療方式後並無顯著療效,且等待腎臟移植並不容易。目前較廣泛治療尿毒搔癢的外用治療方法如下: 1.潤膚劑(emollients) 是尿毒搔癢的首選外用治療,針對理學檢查可見乾燥症病徵的患者更建議使用。 2.局部止痛劑(如pramoxine) 可緩解搔癢。在一家製藥公司贊助的隨機試驗中,其中包括28例血液透析患者,比較每日兩次使用pramoxine與僅使用潤膚劑,發現使用pramoxine的患者搔癢改善較為明顯(分別為61和12%)。Pramoxine在這次試驗中被證明是安全和方便的。建議使用於已規律使用潤膚劑仍持續有搔癢出現的病患。 3.精油(essential oils),以增加角質層含水量。在一個為期2週、隨機、安慰劑為控制組的研究,將病患分為兩組,一組使用2.2%次亞麻油酸(γ-lynolenic acid)乳膏一天三次,另一組使用安慰劑乳膏一天三次,結果發現使用次亞麻油酸乳膏較安慰劑組能有效降低搔癢的症狀。In addition, since the pathophysiology of uremia pruritus has not been fully studied, the most effective treatment is still not available. For patients with severe pruritus, even though the optimal Kt/V target is reached, pruritus is still not available. improve. Uremia and pruritus are treated with oral antihistamines and gabapentin, topical emollients or local analgesics, ultraviolet B (UVB) phototherapy, and kidney transplantation. However, there are many patients with intractable uremia and pruritus in the clinic, after receiving the above treatment methods, there is no significant effect, and it is not easy to wait for a kidney transplant. At present, the more widely used external treatment methods for the treatment of uremia and itching are as follows: 1. Emollients (emollients) are the first choice for topical treatment of uremia and itching, and it is more recommended for patients with symptoms of sjogren on physical examination. 2. Local analgesics (such as pramoxine) can relieve itching. In a randomized trial sponsored by a pharmaceutical company, which included 28 hemodialysis patients, comparing the use of pramoxine twice a day with the emollient alone, it was found that patients who used pramoxine improved significantly (61 and 12%, respectively). Pramoxine proved to be safe and convenient in this trial. It is recommended for patients who have been using emollients regularly and still have persistent itching. 3. Essential oils to increase the water content of the stratum corneum. In a 2-week, randomized, placebo-controlled study, patients were divided into two groups, one group was treated with 2.2% linoleic acid (γ-lynolenic acid) cream three times a day, and the other group was treated with placebo The cream was used three times a day, and it was found that the use of sublinoleic acid cream was more effective in reducing the symptoms of itching than the placebo group.

然而,仍有許多患者使用以上西醫的外用治療雖然對於搔癢的情況有一時的改善,但長久下來搔癢的強況還是無法得到較好的控制,況且上述之治療方式無法有效修復皮膚上已產生之傷口,導致傷口修復緩慢,同時又因搔癢的緣故使得傷口更難癒合,因此是否有別於傳統西醫的治療方式便成為醫學界需要思考並研究的目標。However, there are still many patients who use the above-mentioned external treatments of Western medicine to improve the itching situation for a while, but the intensity of itching can not be better controlled for a long time, and the above-mentioned treatment methods cannot effectively repair the existing skin. Wounds cause slow wound repair, and at the same time, itching makes it more difficult to heal wounds. Therefore, whether the treatment is different from traditional Western medicine has become a goal that the medical community needs to think about and study.

有鑑於此,本發明人感其未臻完善而竭其心智苦心研究,並憑其從事該項產業多年之累積經驗,進而提供一種止癢脫敏之醫藥組合物及其產品之製備方法,以期可以改善上述習知技術之缺失。In view of this, the inventor feels that he is not perfect and exhausts his mental and painstaking research, and based on his accumulated experience in this industry for many years, he provides an antipruritic and desensitizing pharmaceutical composition and a preparation method of its product, in the hope that To improve the lack of the above-mentioned conventional technology.

本發明之一目的,旨在提供一種止癢脫敏之醫藥組合物及其產品之製備方法,以純天然漢方草本之成分製作成醫藥組合物,而達到保濕止癢,也可以助於傷口修復。One objective of the present invention is to provide an antipruritic and desensitizing medicinal composition and a preparation method of its product. The medicinal composition is made from pure natural Chinese herbal ingredients to achieve moisturizing and relieving itching and also help wound healing.

於是,本發明揭露一種止癢脫敏之醫藥組合物,其特徵在於:該醫藥組合物係具有荊芥、防風、地膚子、白鮮皮以及其他草本精華。Therefore, the present invention discloses an antipruritic and desensitizing medicinal composition, which is characterized in that the medicinal composition contains nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal essences.

較佳者,該醫藥組合物之施用方式係選自以下族群之一或其組合:精油、乳液、乳霜、溶液、懸浮液或油膏。Preferably, the method of administration of the pharmaceutical composition is selected from one or a combination of the following groups: essential oils, emulsions, creams, solutions, suspensions or ointments.

此外,本發明另外提供一種止癢脫敏精油之製備方法,其步驟包含:取荊芥、防風、地膚子、白鮮皮以及其他草本精華;將上述成分加入植物萃取油後,加熱沸騰後維持一定溫度煮一段時間;及油萃後再過濾雜質後即可得出該止癢脫敏精油。In addition, the present invention also provides a method for preparing antipruritic and desensitizing essential oils. The steps include: taking nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal extracts; adding the above-mentioned ingredients to the plant extract oil, heating and boiling to maintain Boil at a certain temperature for a period of time; and after the oil is extracted and the impurities are filtered, the anti-itching and desensitizing essential oil can be obtained.

並且,本發明亦提供一種止癢脫敏藥膏之製備方法,其步驟包含:取荊芥、防風、地膚子、白鮮皮以及其他草本精華;將上述成分加入植物萃取油後,加熱沸騰後維持一定溫度煮一段時間;油萃後再過濾雜質;及加入精製植物性油脂與精製動物分泌物後賦型,即可得出該止癢脫敏藥膏。In addition, the present invention also provides a method for preparing antipruritic and desensitizing ointment. The steps include: taking nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal extracts; adding the above-mentioned ingredients to the plant extract oil, heating and boiling to maintain Boil at a certain temperature for a period of time; after oil extraction, impurities are filtered; and refined vegetable oils and refined animal secretions are added and then shaped, the antipruritic and desensitizing ointment can be obtained.

又,本發明還提供一種止癢脫敏乳霜或止癢脫敏乳液之製備方法,其步驟包含:取荊芥、防風、地膚子、白鮮皮以及其他草本精華;將上述成分加入植物萃取油後,加熱沸騰後維持一定溫度煮一段時間;油萃後再過濾雜質;加入精製植物性油脂與植物乳化蠟,並加熱至熔解;及加入純水後持續攪拌即可得出該止癢脫敏乳霜或該止癢脫敏乳液。In addition, the present invention also provides an anti-itch and desensitization cream or a preparation method of anti-itch and desensitization emulsion, the steps of which include: taking nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal extracts; adding the above-mentioned ingredients to plant extracts After the oil is heated and boiled, it is maintained at a certain temperature and boiled for a period of time; after the oil is extracted, the impurities are filtered; the refined vegetable oil and vegetable emulsified wax are added, and heated to melt; and after adding pure water, continue to stir to obtain the anti-itching off Sensitive cream or the anti-itch and desensitizing lotion.

如此一來,透過上述之製備方法以及所製出之醫藥組合物,就能夠於塗抹在傷口或是病症發生處後,產生抗發炎、活血滋潤、與修復皮膚之功效,而且這樣透過完全由純天然漢方草本所組成之醫藥組合物,可以在傷口或搔癢處停留更久,更利於傷口的修復及提升止癢的效果,同時又因天然草本的關係,所以就算是長時間停留在傷口處亦不會對皮膚產生其他不良變化,如過敏等。In this way, through the above-mentioned preparation method and the prepared pharmaceutical composition, it can produce anti-inflammatory, invigorating blood moisturizing, and repairing skin effects after being applied to the wound or the place where the disease occurs. The medicinal composition composed of natural Kampo herbs can stay longer on the wound or itching, which is more conducive to the repair of the wound and the improvement of the antipruritic effect. At the same time, due to the relationship of natural herbs, it can stay on the wound for a long time. Will not produce other undesirable changes to the skin, such as allergies.

為使本領域具有通常知識者能清楚了解本發明之內容,謹以下列說明搭配圖式,敬請參閱。In order to enable those with ordinary knowledge in the field to clearly understand the content of the present invention, please refer to the following description and drawings.

以下係提出不同的實施例,以供展現本發明所提供之醫藥組合物的實際功效,而本發明所提供之該醫藥組合物係具有荊芥、防風、地膚子、白鮮皮以及其他草本精華,且在這些實施例中係利用藥膏的方式進行塗抹治療,而製備方法係為如同發明內容所述,但亦可以用乳液、乳霜或精油的方式進行塗抹,同樣可以達到相同的功效。The following are different examples to show the actual effect of the pharmaceutical composition provided by the present invention, and the pharmaceutical composition provided by the present invention has nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal essences And in these examples, ointment is used for application treatment, and the preparation method is as described in the content of the invention, but it can also be applied in the form of lotion, cream or essential oil, and the same effect can also be achieved.

第一實施例The first embodiment

請參閱第1圖和第2圖,其係為本發明第一實施例之治療前後的搔癢量表示意圖和治療前後的皮損改善狀況圖。如圖所示,本實施例之病患已經過血液透析10年,搔癢9年,經常搔抓至流血,身上的衣物總是血跡斑斑,身上滿是尿毒痘與抓痕,如第2圖中20181121之示意,半夜搔抓失眠,也影響了枕邊人,9年來四處求醫,嘗試過多種治療皆無效。當蕭先生第一次來就診時對其做搔癢量表的評估,如第1圖左側20181017所示,屬於非常嚴重的等級。而在接受該醫藥組合物之塗抹治療後,搔癢程度大減,睡眠品質也大幅改善,就如第1圖中曲線持續向右下移動所示,皮膚傷口改善並收口,就如第2圖中20181121和20190419兩組的照片對照所示,亦可看出圖中詳細記錄了皮損的改善狀況。從上述可知,該醫藥組合物確實對搔癢程度、傷口及病症具有足夠的修復力及抑制力,相較於傳統的治療法來說,亦確實具有先前技術所未有的功效。Please refer to Figures 1 and 2, which are schematic diagrams of the itching scale before and after treatment and diagrams of the improvement of skin lesions before and after treatment according to the first embodiment of the present invention. As shown in the figure, the patient in this example has been on hemodialysis for 10 years, has itchy for 9 years, often scratches until bleeding, the clothes on his body are always bloody, and his body is covered with uremic acne and scratches, as shown in Figure 2. According to 20181121, scratching and insomnia in the middle of the night also affected the person next to the pillow. In the past 9 years, I have sought medical treatment and tried a variety of treatments to no avail. When Mr. Xiao came to the doctor for the first time, he was evaluated by the Itching Scale. As shown in 20181017 on the left side of the first figure, it belongs to a very serious level. After receiving the application of the pharmaceutical composition, the degree of itching was greatly reduced, and the quality of sleep was also greatly improved, as shown by the continuous downward movement of the curve in the first figure, the skin wound improved and closed, as shown in the second figure. The photos of 20181121 and 20190419 are compared, and it can be seen that the improvement of the skin lesions is recorded in detail in the figure. It can be seen from the above that the pharmaceutical composition does have sufficient repairing power and inhibiting power for the degree of itching, wounds and diseases. Compared with the traditional treatment method, it also has the effect that the prior art has not achieved.

第二實施例Second embodiment

請參閱第3圖和第4圖,其係為本發明第二實施例之治療前後的搔癢量表示意圖和治療前後的皮損改善狀況圖。如圖所示,本實施例之病患則是經過腹膜透析6年,搔癢2年,當李先生第一次來就診時對其做搔癢量表的評估,屬於非常嚴重的等級,如第3圖左側20181205所示,其搔癢嚴重影響病患之睡眠,且手臂上有大面積的皮膚穿透瘡,如第4圖最左側20191205之示意,傷口除了搔癢之外,長期以來無法收口,時常需要以刀片割傷口流出黑血才得以止癢。但是,在接受該醫藥組合物之塗抹治療後,搔癢程度大減,就如第3圖中曲線雖有震盪但依舊持續向右下移動所示,而且皮膚傷口亦有顯著改善並收口,就如第4圖中20191205、20190102、20190128至20190325這4個時間段所分別拍攝的照片相互對照所示,亦可看出圖中詳細記錄了皮損的改善狀況。Please refer to Figures 3 and 4, which are schematic diagrams of the pruritus scale before and after treatment and diagrams of the improvement of skin lesions before and after treatment according to the second embodiment of the present invention. As shown in the figure, the patient in this example has undergone peritoneal dialysis for 6 years and has itching for 2 years. When Mr. Li came to see the doctor for the first time, he was evaluated on the Itching Scale, which is a very serious grade, such as the third As shown in 20181205 on the left side of the picture, its itching seriously affects the patient’s sleep, and there are large areas of skin penetrating sores on the arm. As shown in the leftmost side of picture 4, 20191205, the wound has been unable to close the mouth for a long time except for itching, and it is often necessary Cut the wound with a blade to stop the itching with black blood flowing out. However, after receiving the application treatment of the pharmaceutical composition, the degree of itching was greatly reduced, as shown in the curve in Figure 3, although the curve oscillated but continued to move to the lower right, and the skin wound was also significantly improved and closed, just like In Figure 4, the photos taken in the four time periods of 20191205, 20190102, 20190128 and 20190325 are compared with each other. It can also be seen that the improvement of the skin lesions is recorded in detail in the figure.

第三實施例The third embodiment

請參閱第5圖,其係為本發明第三實施例之治療前後的灰指甲改善狀況圖。該醫藥組合物除了可以治療搔癢、過敏及修復傷口之外,亦可以用來治療灰指甲,如第5圖所示,本實施例之病患的灰指甲(甲癬)指甲色黃濁、增厚且易脆碎裂,40年以來皆無法完全治癒(如20190505所示),然而使用該醫藥組合物塗抹治療兩個月後,指甲的黃濁與增厚狀況已明顯改善,碎裂指甲亦有顯著地改善,就如20190505至20190714,這4個時間段所分別拍攝的照片相互對照所示。Please refer to Figure 5, which is a diagram showing the improvement of onychomycosis before and after treatment in the third embodiment of the present invention. In addition to treating itching, allergies and repairing wounds, the pharmaceutical composition can also be used to treat onychomycosis. Thick and fragile, it has not been completely cured for 40 years (as shown in 20190505). However, after two months of treatment with the pharmaceutical composition, the yellowing and thickening of the nails have been significantly improved, and the nails have also been broken. There is a significant improvement, as shown by the comparison of the photos taken in the 4 time periods from 20190505 to 20190714.

綜上所述,透過本發明所提供之該醫藥組合物以及其產品的製備方法,只要將該醫藥組合物塗抹患部就確實可以達到修復傷口,同時又能止癢脫敏之功效,而且由於是純天然漢方草本之成分所製成,因此不會如西醫的藥物一般,可能會對患者的身體造成損害,因此在用藥上亦能較為放心。In summary, through the pharmaceutical composition provided by the present invention and the preparation method of its product, as long as the pharmaceutical composition is applied to the affected part, the wound can be repaired and the effect of relieving itching and desensitization can be achieved, and because it is pure It is made of natural Chinese herbal ingredients, so it is not as good as western medicine, which may cause damage to the patient's body, so it can be more assured in medicine.

惟,以上所述者,僅為本發明之較佳實施例而已,並非用以限定本發明實施之範圍;故在不脫離本發明之精神與範圍下所作之均等變化與修飾,皆應涵蓋於本發明之專利範圍內。However, the above are only the preferred embodiments of the present invention, and are not used to limit the scope of implementation of the present invention; therefore, equal changes and modifications made without departing from the spirit and scope of the present invention should be covered in Within the scope of the patent of the present invention.

第1圖,為本發明第一實施例之治療前後的搔癢量表示意圖。 第2圖,為本發明第一實施例之治療前後的皮損改善狀況圖。 第3圖,為本發明第二實施例之治療前後的搔癢量表示意圖。 第4圖,為本發明第二實施例之治療前後的皮損改善狀況圖。 第5圖,為本發明第三實施例之治療前後的灰指甲改善狀況圖。Figure 1 is a schematic diagram of the pruritus scale before and after treatment in the first embodiment of the present invention. Figure 2 is a diagram showing the improvement of skin lesions before and after treatment in the first embodiment of the present invention. Figure 3 is a schematic diagram of the pruritus scale before and after treatment in the second embodiment of the present invention. Figure 4 is a diagram showing the improvement of skin lesions before and after treatment in the second embodiment of the present invention. Figure 5 is a diagram showing the improvement of onychomycosis before and after treatment in the third embodiment of the present invention.

Claims (5)

一種止癢脫敏之醫藥組合物,其特徵在於: 該醫藥組合物係具有荊芥、防風、地膚子、白鮮皮以及其他草本精華。A pharmaceutical composition for relieving itching and desensitization, which is characterized in: The medical composition contains nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal essences. 如請求項1之醫藥組合物,其中,該醫藥組合物之施用方式係選自以下族群之一或其組合:精油、乳液、乳霜、溶液、懸浮液或油膏。The pharmaceutical composition of claim 1, wherein the method of administration of the pharmaceutical composition is selected from one or a combination of the following groups: essential oils, emulsions, creams, solutions, suspensions or ointments. 一種止癢脫敏精油之製備方法,其步驟包含: 取荊芥、防風、地膚子、白鮮皮以及其他草本精華; 將上述成分加入植物萃取油後,加熱沸騰後維持一定溫度煮一段時間;及 油萃後再過濾雜質後即可得出該止癢脫敏精油。A preparation method of antipruritic and desensitizing essential oil, the steps include: Take nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal extracts; After adding the above-mentioned ingredients to the plant extract oil, it is heated and boiled and kept at a certain temperature for a period of time; and After the oil is extracted, the impurities can be filtered to obtain the antipruritic and desensitizing essential oil. 一種止癢脫敏藥膏之製備方法,其步驟包含: 取荊芥、防風、地膚子、白鮮皮以及其他草本精華; 將上述成分加入植物萃取油後,加熱沸騰後維持一定溫度煮一段時間; 油萃後再過濾雜質;及 加入精製植物性油脂與精製動物分泌物後賦型,即可得出該止癢脫敏藥膏。A preparation method of antipruritic and desensitizing ointment, the steps include: Take nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal extracts; After adding the above-mentioned ingredients to the plant extract oil, it is heated and boiled and kept at a certain temperature for a period of time; Filter impurities after oil extraction; and After adding refined vegetable oils and refined animal secretions, the anti-itch and desensitization ointment can be obtained. 一種止癢脫敏乳霜或止癢脫敏乳液之製備方法,其步驟包含: 取荊芥、防風、地膚子、白鮮皮以及其他草本精華; 將上述成分加入植物萃取油後,加熱沸騰後維持一定溫度煮一段時間; 油萃後再過濾雜質; 加入精製植物萃取油與植物乳化蠟,並加熱至熔解;及 加入純水後持續攪拌即可得出該止癢脫敏乳霜或該止癢脫敏乳液。A preparation method of anti-itch and desensitization cream or anti-itch and desensitization lotion, the steps of which include: Take nepeta, parsnip, Kochia scoparia, white fresh peel and other herbal extracts; After adding the above-mentioned ingredients to the plant extract oil, it is heated and boiled and kept at a certain temperature for a period of time; Filter impurities after oil extraction; Add refined plant extract oil and plant emulsified wax, and heat to melt; and After adding pure water, continue to stir to obtain the anti-itch and desensitization cream or the anti-itch and desensitization emulsion.
TW109105886A 2020-02-24 2020-02-24 Pharmaceutical composition for itching stop and sensitizing relief and manufacturing method thereof wherein the composition includes nepeta, parsnip, Kochia scoparia, Cortex Dictamni and other herbal extracts TW202131939A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW109105886A TW202131939A (en) 2020-02-24 2020-02-24 Pharmaceutical composition for itching stop and sensitizing relief and manufacturing method thereof wherein the composition includes nepeta, parsnip, Kochia scoparia, Cortex Dictamni and other herbal extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109105886A TW202131939A (en) 2020-02-24 2020-02-24 Pharmaceutical composition for itching stop and sensitizing relief and manufacturing method thereof wherein the composition includes nepeta, parsnip, Kochia scoparia, Cortex Dictamni and other herbal extracts

Publications (1)

Publication Number Publication Date
TW202131939A true TW202131939A (en) 2021-09-01

Family

ID=78777512

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109105886A TW202131939A (en) 2020-02-24 2020-02-24 Pharmaceutical composition for itching stop and sensitizing relief and manufacturing method thereof wherein the composition includes nepeta, parsnip, Kochia scoparia, Cortex Dictamni and other herbal extracts

Country Status (1)

Country Link
TW (1) TW202131939A (en)

Similar Documents

Publication Publication Date Title
CN105213284A (en) A kind of anti-acne moisturiser and preparation method thereof
CN104147533B (en) A kind of promoting blood circulation, removing blood stasis and relieving pain emulsifiable paste and preparation method thereof
CN112426390A (en) Natural traditional Chinese medicine acne-removing composition and preparation method thereof
CN112826900B (en) Traditional Chinese medicine composition for treating seborrheic alopecia and pharmaceutical preparation thereof
TWI756638B (en) Use of preparing a pharmaceutical composition for external use to treat itching or allergic symptoms and preparation method of the pharmaceutical composition for external use
CN102274380B (en) External applied medicine for treating burn and scalding
CN107669935A (en) A kind of Chinese medicine antiallergy beauty mask and preparation method thereof
TW202131939A (en) Pharmaceutical composition for itching stop and sensitizing relief and manufacturing method thereof wherein the composition includes nepeta, parsnip, Kochia scoparia, Cortex Dictamni and other herbal extracts
CN105999105A (en) Traditional Chinese medicine composition for treating bedsores and diabetic ulcers and preparation method thereof
WO2018082117A1 (en) External traditional chinese medicine composition having function of removing red blood in skin and skin care preparation thereof
CN105213285A (en) A kind of anti-acne facial cleanser and preparation method thereof
CN109125641A (en) Compound cortex dictamni ointment and preparation method thereof
CN103223158B (en) External medicine for treating alopecia
CN105832940A (en) Medicine for treating acne and acne pits and preparing method thereof
CN111544523A (en) Traditional Chinese medicine composition for treating skin ulceration and application thereof
CN105125814B (en) It is a kind of to treat chronic renal failure III, the Chinese medicine composition of IV phase
CN105168881B (en) It is a kind of to treat chronic renal failure I, the Chinese medicine composition of II phase
CN108815268A (en) A kind of external application promotees the Chinese medicine ointment formulation and preparation method thereof of union of wounded skin
CN108619042A (en) A kind of breast nutrition and health care promoting blood circulation and removing blood stasis applies some make up and preparation method thereof
CN112972645A (en) Production process of medicinal oil for treating meridian diseases
CN104147246A (en) Instant medicine for treating chronic eczema and preparation method thereof
CN105250444A (en) Traditional Chinese medicinal liniment for treating skin itch and preparation method of traditional Chinese medicinal liniment
CN115154550A (en) External traditional Chinese medicine composition for treating ulcer type tuberculous lymphadenitis
CN102813854B (en) Chinese herbal medicine paste used for treating acne
CN112826831A (en) Traditional Chinese medicine composition for treating skin diseases, preparation method and application